Triglycerides and the Risk of Coronary Heart Disease

Ovid Technologies (Wolters Kluwer Health) - Tập 115 Số 4 - Trang 450-458 - 2007
Nadeem Sarwar1,2,3, John Danesh1,2,3, Guðný Eiríksdóttir1,2,3, Gunnar Sigurðsson1,2,3, Nicholas J. Wareham1,2,3, Sheila Bingham1,2,3, S. Matthijs Boekholdt1,2,3, Kay‐Tee Khaw1,2,3, Vilmundur Guðnason1,2,3
1Academic Medical Center, Amsterdam, the Netherlands (S.M.B.).
2From the Department of Public Health and Primary Care, University of Cambridge (N.S., J.D., K.-T.K.), MRC Epidemiology Unit (N.W.), MRC Dunn Nutrition Unit, and MRC Centre for Nutrition and Cancer Prevention and Survival (S.B.), Cambridge, England; Icelandic Heart Association, Kopavogur, Iceland (G.E., G.S., V.G.); and Academic Medical Center, Amsterdam, the Netherlands (S.M.B.).
3Icelandic Heart Association, Kopavogur, Iceland (G.E., G.S., V.G.)

Tóm tắt

Background— Many epidemiological studies have reported on associations between serum triglyceride concentrations and the risk of coronary heart disease, but this association has not been reliably quantified. In the present study, we report 2 separate nested case-control comparisons in 2 different prospective, population-based cohorts, plus an updated meta-analysis of 27 additional prospective studies in general Western populations.

Methods and Results— Measurements were made in a total of 3582 incident cases of fatal and nonfatal coronary heart disease and 6175 controls selected from among the 44 237 men and women screened in the Reykjavik and the European Prospective Investigation of Cancer (EPIC)-Norfolk studies. Repeat measurements were obtained an average of 4 years apart in 1933 participants in the EPIC-Norfolk Study and an average of 12 years apart in 379 participants in the Reykjavik study. The long-term stability of log-triglyceride values (within-person correlation coefficients of 0.64 [95% CI, 0.60 to 0.68] over 4 years and 0.63 [95% CI, 0.57 to 0.70] over 12 years) was similar to those of blood pressure and total serum cholesterol. After adjustment for baseline values of several established risk factors, the strength of the association was substantially attenuated, and the adjusted odds ratio for coronary heart disease was 1.76 (95% CI, 1.39 to 2.21) in the Reykjavik study and 1.57 (95% CI, 1.10 to 2.24) in the EPIC-Norfolk study in a comparison of individuals in the top third with those in the bottom third of usual log-triglyceride values. Similar overall findings (adjusted odds ratio, 1.72; 95% CI, 1.56 to 1.90) were observed in an updated meta-analysis involving a total of 10 158 incident coronary heart disease cases from 262 525 participants in 29 studies.

Conclusions— Available prospective studies in Western populations consistently indicate moderate and highly significant associations between triglyceride values and coronary heart disease risk. Because these associations depend considerably on levels of established risk factors, however, further studies are needed to help assess the nature of any independent associations.

Từ khóa


Tài liệu tham khảo

10.5551/jat.11.6

10.1161/circ.104.10.1108

Wilson P, Larson M, Castelli W. Triglycerides, HDL-cholesterol and coronary artery disease: a Framingham update on their interrelations. Can J Cardiol. 1994; 10: 5B–9B.

10.1136/bmj.307.6915.1318

10.1093/oxfordjournals.aje.a115157

10.1016/S0021-9150(99)00190-2

10.1111/j.1532-5415.2004.52455.x

10.1001/archinte.160.13.1937

10.1136/bmj.298.6679.998

10.1111/j.0954-6820.1982.tb01978.x

10.1001/jama.1996.03540110036029

10.1001/jama.1975.03260080034016

10.1161/01.cir.0000146339.57154.9b

10.1161/circ.97.11.1029

10.1093/ije/12.1.26

10.1056/NEJM199304293281702

10.1016/0002-9149(92)90550-I

10.1161/01.atv.0000035521.22199.c7

10.1093/oxfordjournals.aje.a114435

10.1136/hrt.68.7.60

10.1016/S0002-9149(00)00956-5

10.1016/0002-9149(94)90722-6

10.1016/0021-9150(85)90156-X

10.1136/bmj.2.6096.1185

10.1016/0021-9681(80)90022-3

10.1161/circ.48.5.950

Glynn R, Rosner B, Silbert J. Changes in cholesterol and triglycerides as predictors of ischaemic heart disease in men. Circulation. 1982; 4: 724–731.

10.1136/bmj.307.6916.1385

10.1097/00043798-199604000-00014

10.1161/01.cir.0000145615.33955.83

10.1161/circ.106.25.3143

10.1177/174182670200900201

Day N, Oakes S, Luben R, Khaw KT, Bingham S, Welch A, Wareham N. EPIC-Norfolk study design and characteristics of the cohort: European Prospective Investigation of Cancer. Br J Cancer. 1999; 80: 95–103.

10.1093/oxfordjournals.aje.a010013

10.1001/jama.279.18.1477

10.1136/bmj.327.7414.557

10.1093/aje/154.5.418

10.1056/NEJM196510282731802

10.1016/S0140-6736(05)66378-7

10.1056/NEJM199908053410604

10.1016/S0140-6736(00)04209-4

10.1016/S0140-6736(05)67667-2

10.1186/CVM-2-4-195

10.1136/bmj.330.7499.1076

10.1016/j.atherosclerosis.2004.04.024

10.1194/jlr.M400192-JLR200